Multicenter, open label, randomized controlled superiority trial for availability to reduce nocturnal urination frequency: The TOP-STAR study.

J Diabetes Investig · 2024 · PMC11615697 · PMID 39292166

Europe PMC DOI

hedged sentences

0.0700

closest p · 1.4× alpha

0.0700

boldest claim

The sentences

a decreasing trendP = 0.07so close (0.05 < p ≤ 0.1)

It should be noted that the number of nocturnal urinations ( P = 0.049) significantly decreased in group B, and a decreasing trend was also observed in urine volume ( P = 0.07) during the night.

also in 47,180 other papers

an increasing trendno p-value reported

Furthermore, daytime urine volume and frequency showed an increasing trend, suggesting a shift in urine production to daytime hours due to the short half‐life of tofogliflozin.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.